Merger • Life Science

Lumos Acquires Lumos Pharma

On September 30, 2019, Lumos acquired life science company Lumos Pharma

Acquisition Context

This is Lumos’ 1st transaction in the Life Science sector.
This is Lumos’ 1st transaction in the United States.
This is Lumos’ 1st transaction in Texas.

Explore All 191 Merger Life Science Deals - Search the Database Free

M&A Deal Summary
Date	September 30, 2019
Target	Lumos Pharma
Sector	Life Science
Buyer(s)	Lumos
Deal Type	Merger

Target Company

Lumos Pharma

Austin, Texas, United States

Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare and neglected diseases.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Lumos

Austin, Texas, United States

Category	Company
Founded	2011
Sector	Life Science
Employees	29

DESCRIPTION

Lumos is a clinical-stage biopharmaceutical company focused on developing novel oncology product candidates to improve the lives of patients with cancer where treatment options are limited. Lumos was founded in 2011 and is based in Austin, Texas.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Merger	1 of 1
State: Texas	1 of 1
Country: United States	1 of 1
Year: 2019	1 of 1

Explore Related M&A Activity

Life Science M&A - Merger M&A Deals - Texas M&A - United States M&A - 2019 M&A